title: Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator.
abstract: Circulating thrombomodulin is a novel endothelial cell marker, which may reflect the endothelial injury. Plasma levels of thrombomodulin were quantitated by an enzyme-linked immunosorbent assay (ELISA) in patients with hematological malignancies, liver disease, diabetes mellitus, collagen disease, thrombotic disease, and disseminated intravascular coagulation (DIC), and the thrombomodulin values were compared with those of von Willebrand factor antigen (vWf:Ag) and tissue-type plasminogen activator (t-PA) which are released from stimulated or damaged endothelial cells. The mean plasma concentrations of thrombomodulin in these disease states were elevated as compared with healthy subjects. A relatively high mean thrombomodulin level was observed in DIC, liver disease, and collagen disease. Abnormally high thrombomodulin values (greater than normal mean value + 3 SD) were found in 32.3% of patients with hematological malignancies, 57.7% of patients with liver disease, 39.3% of patients with diabetes mellitus, 30.0% of patients with collagen disease, 23.1% of patients with thrombotic disease, and 69.0% of patients with DIC. Plasma concentrations of both vWf:Ag and t-PA were also elevated in these patients. On the whole, the plasma thrombomodulin concentration was positively correlated with vWf:Ag (r = 0.441, P less than 0.001) and t-PA (r = 0.398, P less than 0.001). These findings indicate that the elevation of plasma thrombomodulin is frequently seen in a variety of diseases and circulating thrombomodulin is possibly useful for evaluating the endothelial damage in selected disease states.
authors.affiliation: First Department of Internal Medicine, Niigata University School of Medicine, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Takahashi
authors.forename: S
authors.initials: S
authors.lastname: Ito
authors.forename: M
authors.initials: M
authors.lastname: Hanano
authors.forename: K
authors.initials: K
authors.lastname: Wada
authors.forename: H
authors.initials: H
authors.lastname: Niwano
authors.forename: Y
authors.initials: Y
authors.lastname: Seki
authors.forename: A
authors.initials: A
authors.lastname: Shibata
mesh_terms: D015415:Biomarkers / Q000097:blood; D003095:Collagen Diseases / Q000097:blood / Q000473:pathology; D003920:Diabetes Mellitus / Q000097:blood / Q000473:pathology; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000473:pathology; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology* / Q000502:physiology; D004797:Enzyme-Linked Immunosorbent Assay; D006402:Hematologic Diseases / Q000097:blood / Q000473:pathology; D006801:Humans; D011956:Receptors, Cell Surface / Q000032:analysis*; D018179:Receptors, Thrombin; D013927:Thrombosis / Q000097:blood / Q000473:pathology; D010959:Tissue Plasminogen Activator / Q000097:blood*; D014841:von Willebrand Factor / Q000032:analysis*
chemical_list: D015415:Biomarkers; D011956:Receptors, Cell Surface; D018179:Receptors, Thrombin; D014841:von Willebrand Factor; D010959:Tissue Plasminogen Activator